NCT04215822 2020-01-03
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia
Assiut University
Unknown
Clinical Trials
7 trialsNCT01424865 2015-05-08
Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial
NSABP Foundation Inc
Unknown
NCT00671476 2014-01-10
Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
National Cancer Institute (NCI)
Phase NA Unknown
NCT00360945 2013-09-17
Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00989690 2013-08-12
Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01653613 2013-07-10
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
Unknown
NCT00874146 2010-09-02
Level of HER2-neu Gene Amplification an Response to Trastuzumab
Istituto Clinico Humanitas
Unknown